Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-01410 | MA-PEG4-VC-PAB-MMAE | 2851435-57-7 |
| MA-PEG4-VC-PAB-MMAE is a thiol-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01411 | MPB-VC-PAB-DM1 | |
| MPB-VC-PAB-DM1 is a thiol-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01412 | MA-PEG4-VC-PAB-DMAE-Doxorubicin | |
| MA-PEG4-VC-PAB-DMAE-Doxorubicin is a thiol-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01413 | DBM-MMAE | 1912408-87-7 |
| DBM-MMAE is a thiol-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01414 | CL2A-Chimmitecan | |
| CL2A-Chimmitecan is a thiol-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01415 | DM21 | 2243689-80-5 |
| DM21 is a profound biomedical product employed for combating cancer and inflammation. It showcases its remarkable prowess in thwarting malignant tumor progression and alleviating inflammatory responses through precise modulation of distinctive molecular cascades. Vigorously investigated and validated, DM21 emerges as an inhibitory force impeding tumor proliferation whilst mitigating inflammatory disorders, thus proffering a wide array of promising therapeutic avenues in the realm of diverse cancer categories and inflammatory afflictions. | Inquiry | |
| BADC-01416 | C-lock-PEG4-MMAE | |
| C-lock-PEG4-MMAE is a thiol-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01417 | MC-VC-PAB-DMEA-PNU159682 | 1178887-17-6 |
| MC-VC-PAB-DMEA-PNU159682 is a thiol-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01418 | C-lock-G5-Dxd | |
| C-lock-G5-Dxd is a thiol-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01419 | C-lock-GGFG-Dxd | |
| C-lock-GGFG-Dxd is a thiol-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01420 | C-lock-GGFG-Exatecan | |
| C-lock-GGFG-Exatecan is a thiol-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01421 | DBCO-PEG4-GGFG-DMEA-PNU159682 | |
| DBCO-PEG4-GGFG-DMEA-PNU159682 is a click-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01422 | DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA) | |
| DBCO-PEG4-VC-PAB-DMEA-((S)-Seco-Duocarmycin SA) is a click-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01423 | NH2-PEG3-DMEA-PNU159682 | |
| NH2-PEG3-DMEA-PNU159682 is a sortase-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01424 | NH2-VC-PAB-DMEA-PNU159682 | 2227350-96-9 |
| NH2-VC-PAB-DMEA-PNU159682 is a sortase-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01425 | NH2-PEG4-VC-PAB-DMEA-SN38 | |
| NH2-PEG4-VC-PAB-DMEA-SN38 is a sortase-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01426 | VA-PAB-DMEA-PNU159682 | 2414872-62-9 |
| VA-PAB-DMEA-PNU159682 is a sortase-reactive drug-linker conjugate used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01432 | Cys-MC-MMAF | 1160590-05-5 |
| Cys-MC-MMAF is the released payload of AlMcMMAF, an anti-5T4 humanized A1 antibody that is conjugated to microtubule MMAF destruction via a maleimidocaproyl linker. It has antitumor effects on two tumor mouse models (H1975 and MDA-MB-361-DYT2). | Inquiry | |
| BADC-01433 | N-Ac-Cys-LND1025 | |
| N-Ac-Cys-LND1025 is an ADC metabolite used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01434 | Cys-MC-VC-PAB-MMAE | |
| Cys-MC-VC-PAB-MMAE is an ADC metabolite used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry |
